Alicia C. Olivo - 01 Sep 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: General Counsel
Signature: /s/ Alicia C. Olivo
Issuer symbol: NEO
Transactions as of: 01 Sep 2024
Net transactions value: $0
Form type: 4
Filing time: 04 Sep 2024, 16:08:12 UTC
Previous filing: 19 Aug 2024
Next filing: 19 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Tax liability	$0	-1,666	-3.8%	$0.000000	42,147	01 Sep 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NEO	Stock Option (Right to Buy)						1,046	01 Sep 2024	Common Stock	1,046	$19.12	Direct	F2
holding	NEO	Stock Option (Right to Buy)						1,024	01 Sep 2024	Common Stock	1,024	$27.34	Direct	F3
holding	NEO	Stock Option (Right to Buy)						516	01 Sep 2024	Common Stock	516	$48.99	Direct	F4
holding	NEO	Stock Option (Right to Buy)						1,117	01 Sep 2024	Common Stock	1,117	$46.10	Direct	F5
holding	NEO	Stock Option (Right to Buy)						22,222	01 Sep 2024	Common Stock	22,222	$9.45	Direct	F6
holding	NEO	Stock Option (Right to Buy)						55,332	01 Sep 2024	Common Stock	55,332	$10.05	Direct	F7
holding	NEO	Stock Option (Right to Buy)						36,508	01 Sep 2024	Common Stock	36,508	$19.65	Direct	F8
holding	NEO	Performance Stock Unit						19,508	01 Sep 2024	Common Stock	19,508	$0.000000	Direct	F9, F10
holding	NEO	Restricted Stock Unit						13,006	01 Sep 2024	Common Stock	13,006	$0.000000	Direct	F10, F11
holding	NEO	Stock Option (Right to Buy)						42,344	01 Sep 2024	Common Stock	42,344	$16.45	Direct	F12
holding	NEO	Performance Stock Unit						25,330	01 Sep 2024	Common Stock	25,330	$0.000000	Direct	F10, F13
holding	NEO	Restricted Stock Unit						25,329	01 Sep 2024	Common Stock	25,329	$0.000000	Direct	F10, F14

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares surrendered to NeoGenomics, Inc. for retirement to satisfy the tax obligations in connection with the September 1, 2024 vesting of restricted stock.
F2	On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vested ratably over the first four anniversary dates of the grant date.
F3	On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F4	On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F5	On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F6	On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F7	On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F8	On May 11, 2023, Ms. Olivo was granted 36,508 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F9	On May 11, 2023, Ms. Olivo was granted 19,508 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 29,262. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
F10	Once vested, the shares of common stock are not subject to expiration.
F11	On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F12	On February 23, 2024, Ms. Olivo was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F13	On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
F14	On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.